3-Fluoromethamphetamine

3-Fluoromethamphetamine
Legal status
Legal status	CA: Schedule I; DE: Anlage I (Authorized scientific use only); UK: Class A; US: Unscheduled;
Identifiers
	IUPAC name (RS)-1-(3-fluorophenyl)-N-methylpropan-2-amine;
CAS Number	1182818-14-9 ;
PubChem CID	58216164;
ChemSpider	27050449 ;
UNII	E5356E50BR;
CompTox Dashboard (EPA)	DTXSID20728951 ;
Chemical and physical data
Formula	C10H14FN
Molar mass	167.227 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES FC1=CC=CC(CC(NC)C)=C1;
	InChI InChI=1S/C10H14FN/c1-8(12-2)6-9-4-3-5-10(11)7-9/h3-5,7-8,12H,6H2,1-2H3; Key:RRVAUTPWWWFYQT-UHFFFAOYSA-N;

3-Fluoromethamphetamine (3-FMA) is a stimulant drug related to methamphetamine and 3-fluoroamphetamine. It has been sold online as a designer drug.^[2]^[3]^[4]^[5]

Legal status

Canada

As of 1996, 3-FMA is a controlled substance in Canada, due to being an analog of methamphetamine.^[1]

China

As of October 2015, 3-FMA is a controlled substance in China.^[6]

United States

As a close analog of scheduled controlled substance,^[7] sale or possession of 3-FMA could be potentially be prosecuted under the Federal Analogue Act.^[8]

References

^ ^a ^b Branch, Legislative Services (2022-03-31). "Consolidated federal laws of Canada, Controlled Drugs and Substances Act". laws-lois.justice.gc.ca. Archived from the original on 2022-06-11. Retrieved 2022-08-11.
^ Westphal F, Rösner P, Junge T (January 2010). "Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry". Forensic Science International. 194 (1–3): 53–9. doi:10.1016/j.forsciint.2009.10.007. PMID 19900772.
^ Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, et al. (April 2012). "Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View, and the Emit assays for use in drug enforcement". Forensic Science International. 217 (1–3): 174–81. doi:10.1016/j.forsciint.2011.11.003. PMID 22154438.
^ Kauppila TJ, Flink A, Haapala M, Laakkonen UM, Aalberg L, Ketola RA, Kostiainen R (July 2011). "Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs". Forensic Science International. 210 (1–3): 206–12. doi:10.1016/j.forsciint.2011.03.018. PMID 21474259.
^ Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (July 2013). "Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry". Forensic Toxicology. 31 (2): 241–250. doi:10.1007/s11419-013-0184-7. S2CID 23323323.
^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
^ Rösner P, Quednow B, Girreser U, Junge T (March 2005). "Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs)". Forensic Science International. 148 (2–3): 143–56. doi:10.1016/j.forsciint.2004.05.003. PMID 15639609.
^ "Federal Controlled Substance Analogue Act Summary". Erowid Analog Law Vault.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[:1-1] Branch, Legislative Services (2022-03-31). "Consolidated federal laws of Canada, Controlled Drugs and Substances Act". laws-lois.justice.gc.ca. Archived from the original on 2022-06-11. Retrieved 2022-08-11.

[2] Westphal F, Rösner P, Junge T (January 2010). "Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry". Forensic Science International. 194 (1–3): 53–9. doi:10.1016/j.forsciint.2009.10.007. PMID 19900772.

[3] Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, et al. (April 2012). "Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View, and the Emit assays for use in drug enforcement". Forensic Science International. 217 (1–3): 174–81. doi:10.1016/j.forsciint.2011.11.003. PMID 22154438.

[4] Kauppila TJ, Flink A, Haapala M, Laakkonen UM, Aalberg L, Ketola RA, Kostiainen R (July 2011). "Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs". Forensic Science International. 210 (1–3): 206–12. doi:10.1016/j.forsciint.2011.03.018. PMID 21474259.

[5] Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (July 2013). "Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry". Forensic Toxicology. 31 (2): 241–250. doi:10.1007/s11419-013-0184-7. S2CID 23323323.

[6] "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.

[Rösner-7] Rösner P, Quednow B, Girreser U, Junge T (March 2005). "Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs)". Forensic Science International. 148 (2–3): 143–56. doi:10.1016/j.forsciint.2004.05.003. PMID 15639609.

[:2-8] "Federal Controlled Substance Analogue Act Summary". Erowid Analog Law Vault.

[2]

[3]

[4]

[5]

[1]

[6]

[7]

[8]